Week in Review: September 29–October 3

Feeding beneficial gut bacteria during infection; testing bacteriophage therapies; Central Park’s diverse soil microbiome; Ebola update; BRAIN funding boost

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

JOSEPH PICKARD, UNIVERSITY OF CHICAGOEven when their systemically infected hosts stopped eating, beneficial gut bacteria still received enough food to survive, according to a mouse study published in Nature this week (October 1). Researchers from the University of Chicago and their colleagues identified an immune pathway through which intestinal cells provide commensal microbes with the sugar fucose.

“The host is responding to a systemic microbial infection signal by altering glycans on intestinal epithelial cells, and this in turn increases host fitness in a microbiota-dependent manner,” Laurie Comstock, a microbiologist at the Brigham and Women’s Hospital in Boston who was not involved in the work, told The Scientist.

FLICKR, KEVIN DOOLEYTesting nearly 600 samples, a team led by investigators at Colorado State University has found that the soil beneath New York City’s Central Park is exceptionally diverse. Their work was published in Proceedings of the Royal Society B this week (October 1).

“Interestingly they found that belowground diversity from urban and managed soils have similar diversity to some of known natural ecosystems, which indicate the high resilience of belowground diversity to anthropogenic pressures,” microbial ecologist Brajesh Singh of the University of Western Sydney in Australia who was not involved in the work ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA